Monkeypox unlikely to be eliminated in the U.S., CDC says

The monkeypox virus is unlikely to be eliminated from the U.S. in the near future, according to a report published by the Centers for Disease Control and Prevention this week. The CDC, in a technical brief, said the outbreak is slowing as the availability of vaccines has increased, people have become more aware of how … Read more

Covid vaccination tied to increase in length of menstrual cycle: NIH

A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning … Read more

Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old

Following CDC approval for vaccination of children aged 6 months to 5 years, 4 year-old Eleanor Kahn sits with her father Alex, as nurse Jillian Mercer administers the Moderna vaccine for the coronavirus disease (COVID-19) at Rady Children’s Hospital in San Diego, California, U.S., June 21, 2022. Mike Blake | Reuters Moderna has asked the … Read more

A Cancer-Fighting Version of Herpes Shows Promise in Early Human Trial

A illustration of a herpes simplex virus. Illustration: Shutterstock (Shutterstock) Scientists may be able to turn a long-time germ foe into a cancer-fighting ally, new research this week suggests. In preliminary data from a Phase I trial, a genetically modified version of the herpes virus has shown promise in treating difficult-to-eradicate tumors, with one patient … Read more

Lupin signs pact to supply five biosimilars in Philippines

The pharma major announced that it has signed an exclusive license and supply agreement with DKSH to commercialize five of Alvotech’s proposed biosimilars in the Philippines. DKSH is a leading partner for healthcare companies seeking to grow their business in Asia and beyond. The biosimilars planned under this agreement include are Prolia (denosumab), Xgeva … Read more